WO2014041528A3 - A composition for the treatment of cutaneous signs of ageing - Google Patents

A composition for the treatment of cutaneous signs of ageing Download PDF

Info

Publication number
WO2014041528A3
WO2014041528A3 PCT/IE2013/000018 IE2013000018W WO2014041528A3 WO 2014041528 A3 WO2014041528 A3 WO 2014041528A3 IE 2013000018 W IE2013000018 W IE 2013000018W WO 2014041528 A3 WO2014041528 A3 WO 2014041528A3
Authority
WO
WIPO (PCT)
Prior art keywords
ageing
composition
treatment
cutaneous signs
collagen
Prior art date
Application number
PCT/IE2013/000018
Other languages
French (fr)
Other versions
WO2014041528A2 (en
Inventor
Roslain Margaret MARTIN
Original Assignee
Martin Roslain Margaret
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to IES2012/0401 priority Critical
Priority to IES20120401 priority
Application filed by Martin Roslain Margaret filed Critical Martin Roslain Margaret
Publication of WO2014041528A2 publication Critical patent/WO2014041528A2/en
Publication of WO2014041528A3 publication Critical patent/WO2014041528A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/347Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986Cosmetics or similar toilet preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/676Ascorbic acid, i.e. vitamin C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92Oral administration

Abstract

A composition which can be oral or topical for treating the cutaneous signs of ageing comprising collagen and a combination of Reactive Oxygen Species (ROS) scavengers/antioxidants such Vitamin C, disulfides, tocopherols/tocotrienols, carotenoids and coenzyme Q10 and collagen pre-cursors and use of such compositions for treating cosmetic ageing.
PCT/IE2013/000018 2012-09-14 2013-09-10 A composition WO2014041528A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IES2012/0401 2012-09-14
IES20120401 2012-09-14

Publications (2)

Publication Number Publication Date
WO2014041528A2 WO2014041528A2 (en) 2014-03-20
WO2014041528A3 true WO2014041528A3 (en) 2014-12-18

Family

ID=50278796

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IE2013/000018 WO2014041528A2 (en) 2012-09-14 2013-09-10 A composition

Country Status (1)

Country Link
WO (1) WO2014041528A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201511255D0 (en) * 2015-06-26 2015-08-12 Colltec Ltd Formulation

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19831798A1 (en) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
WO2001017484A2 (en) * 1999-09-07 2001-03-15 D.T.R. Dermal Therapy Research Inc. Topical urea composition
WO2002026207A2 (en) * 2000-09-28 2002-04-04 Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione - Istituto Dermopatico Dell'immacolata Cosmetic formulation
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US20050048008A1 (en) * 2003-08-29 2005-03-03 Bioderm Research Antiaging Cosmetic Delivery Systems
US20060182794A1 (en) * 2005-02-14 2006-08-17 Pankaj Modi Stabilized compositions for topical administration and methods of making same
EP1932514A1 (en) * 2005-10-05 2008-06-18 Ezaki Glico Co., Ltd. Pharmaceutical preparation for external application to skin comprising phosphorylated sugar
WO2009008397A1 (en) * 2007-07-06 2009-01-15 Fujifilm Corporation Cosmetic composition
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
EP2404642A2 (en) * 2010-07-09 2012-01-11 The Direct Marketing Company S.p.A. (brevemente DMC S.p.A.) Process for preparing a cosmetic composition having an immediate lifting effect
WO2012014417A1 (en) * 2010-07-28 2012-02-02 株式会社 資生堂 Use of plant or like for improving pores, method for improving pores and oral preparation for improving pores
WO2012035904A1 (en) * 2010-09-13 2012-03-22 株式会社資生堂 Agent for promoting hyaluronic acid production
EP2727580A1 (en) * 2011-06-28 2014-05-07 Fujifilm Corporation Astaxanthin-containing composition, method for manufacturing same, and cosmetic

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19831798A1 (en) * 1998-07-15 2000-01-27 Mandorlo Investment Gmbh Luxem Microcirculation improving skin and tissue care or treatment composition, containing salts, aminoacids and peroxide, used as cosmetic, medicament or nutrient supplement
WO2000008061A1 (en) * 1998-08-05 2000-02-17 Jasper Ltd. Liability Co. Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions
WO2001017484A2 (en) * 1999-09-07 2001-03-15 D.T.R. Dermal Therapy Research Inc. Topical urea composition
WO2002026207A2 (en) * 2000-09-28 2002-04-04 Provincia Italiana Della Congregazione Dei Figli Dell'immacolata Concezione - Istituto Dermopatico Dell'immacolata Cosmetic formulation
US20040265268A1 (en) * 2001-08-18 2004-12-30 Deepak Jain Compositions and methods for skin rejuvenation and repair
US20050048008A1 (en) * 2003-08-29 2005-03-03 Bioderm Research Antiaging Cosmetic Delivery Systems
US20060182794A1 (en) * 2005-02-14 2006-08-17 Pankaj Modi Stabilized compositions for topical administration and methods of making same
EP1932514A1 (en) * 2005-10-05 2008-06-18 Ezaki Glico Co., Ltd. Pharmaceutical preparation for external application to skin comprising phosphorylated sugar
WO2009008397A1 (en) * 2007-07-06 2009-01-15 Fujifilm Corporation Cosmetic composition
EP2033689A1 (en) * 2007-08-22 2009-03-11 Italfarmacia S.r.l. Injectable dermatological composition for treatment of the wrinkles
EP2404642A2 (en) * 2010-07-09 2012-01-11 The Direct Marketing Company S.p.A. (brevemente DMC S.p.A.) Process for preparing a cosmetic composition having an immediate lifting effect
WO2012014417A1 (en) * 2010-07-28 2012-02-02 株式会社 資生堂 Use of plant or like for improving pores, method for improving pores and oral preparation for improving pores
WO2012035904A1 (en) * 2010-09-13 2012-03-22 株式会社資生堂 Agent for promoting hyaluronic acid production
EP2727580A1 (en) * 2011-06-28 2014-05-07 Fujifilm Corporation Astaxanthin-containing composition, method for manufacturing same, and cosmetic

Also Published As

Publication number Publication date
WO2014041528A2 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
EP2877159B8 (en) Efflux inhibitor compositions and methods of treatment using the same
WO2011088323A3 (en) Low-haze transparent conductors
WO2011123727A3 (en) Organosilicones
MX359327B (en) Methods and compositions for treating huntington's disease.
MX2015001751A (en) Topical composition comprising transformed bacteria expressing a compound of interest.
WO2011107186A3 (en) Compounds for electronic devices
WO2011140202A3 (en) Mif modulators
IN2014DN09118A (en) Biophotonic compositions kits and methods
WO2012077120A3 (en) Natural formulations
WO2014062720A3 (en) Methods of treating cancer
WO2014062733A3 (en) Substituted benzene compounds
MX2013012190A (en) Tetrahydroquinoline derivatives useful as bromodomain inhibitors.
SG10201808661XA (en) Method of treating obesity using antioxidant inflammation modulators
MX2011003853A (en) Compositions and method for breaking hydraulic fracturing fluids.
WO2010027792A8 (en) Treatment of sweating and hyperhidrosis
EP3068905A4 (en) Methods and compositions for treating huntington's disease
IN2014DN10386A (en) Benzo [c] isoxazoloazepine bromodomain inhibitors and uses thereof
WO2009135857A3 (en) Polyurethanes as rheological modifying means for cosmetic preparations
IL224164A (en) 2,3-diphenyl-1,8-naphthyridine and 1,4,8-azanaphthyridine derivatives and pharmaceutical compositions comprising them
WO2012030984A3 (en) Skin compositions and methods of use thereof
WO2006087759A3 (en) Pharmaceutical composition comprising curcumin and resveratrol and uses thereof in medical field
IN2015DN02875A (en) Formulations of enzalutamide
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
WO2013119916A3 (en) Compounds for treating spinal muscular atrophy
WO2013024282A3 (en) Inhibitor or down- regulator of the expression of one or both of tbk1 ikk-epsilon for use in the treatment of pi3kinase dependent cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13776582

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct app. not ent. europ. phase

Ref document number: 13776582

Country of ref document: EP

Kind code of ref document: A2